• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Stallings Robert W converted options into 1,330 shares, bought $34,100 worth of shares (500 units at $68.20) and bought $19,800 worth of Depositary Shares for Series B Preferred Stock (1,000 units at $19.80), increasing direct ownership by 0.64% to 289,961 units (SEC Form 4)

    4/24/25 4:07:09 PM ET
    $TCBI
    Major Banks
    Finance
    Get the next $TCBI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    STALLINGS ROBERT W

    (Last) (First) (Middle)
    2000 MCKINNEY AVENUE
    SUITE 700

    (Street)
    DALLAS TX 75201

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    TEXAS CAPITAL BANCSHARES INC/TX [ TCBI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/23/2025 M 1,330 A $0 289,461 D
    Common Stock 04/23/2025 P 500 A $68.2 289,961 D
    Depositary Shares for Series B Preferred Stock(1) 04/23/2025 P 1,000 A $19.8 228,913 I SCG Ventures LP(2)
    Common Stock 85,039 I SCG Ventures LP(2)
    Depositary Shares for Series B Preferred Stock(1) 49,500 I Stallings Foundation(3)
    Depositary Shares for Series B Preferred Stock(1) 84,587 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    2025 Restricted Stock Units $0 04/22/2025 A 1,670 04/22/2026 (4) Common Stock 1,670 $0 1,670 D
    2024 Restricted Stock Units $0 04/23/2025 M 1,330 04/23/2025 (4) Common Stock 1,330 $0 0 D
    Explanation of Responses:
    1. Each Depositary Share represents a 1/40th interest in a share of the issuer's 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B, par value $.01 per share.
    2. SCG Ventures LP is owned by the RWS Investment Trust (49.5%), the LES Investment Trust (49.5%) and Stallings Management LLC (1%), its general partner. Stallings Management LLC is owned by Mr. and Mrs. Stallings (100%).
    3. The Stallings Foundation is a charitable foundation of which Mr. Stallings is an officer.
    4. N/A
    Remarks:
    Mary Helen Hall, attorney-in-fact 04/24/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TCBI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TCBI

    DatePrice TargetRatingAnalyst
    5/21/2025$80.00Hold
    Jefferies
    4/21/2025$84.00 → $75.00Market Perform
    Hovde Group
    3/7/2025$90.00 → $84.00Market Perform
    Hovde Group
    10/18/2024$73.00 → $79.00Market Perform
    Hovde Group
    10/18/2024$77.00 → $82.00Overweight → Neutral
    Piper Sandler
    9/23/2024$66.00 → $73.00Market Perform
    Hovde Group
    9/17/2024$78.00Mkt Perform → Outperform
    Raymond James
    9/9/2024$51.00 → $77.00Underperform → Buy
    BofA Securities
    More analyst ratings